BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20171017T140000
DTEND;TZID=America/New_York:20171017T150000
DTSTAMP:20260412T230639
CREATED:20171017T180000Z
LAST-MODIFIED:20190307T185824Z
UID:10000932-1508248800-1508252400@www.med.unc.edu
SUMMARY:McAllister Heart Institute Seminar Series: Timothy Haystead\, PhD\, Defining Novel Therapeutic Targets for Cardiovascular Disease through Chemical Biology
DESCRIPTION:Speaker: Timothy Haystead\, PhD\, Professor of Pharmacology and Cancer Biology\, Duke University School of MedicineTopic: Defining Novel Therapeutic Targets for Cardiovascular Disease through Chemical Biology
URL:https://www.med.unc.edu/medicine/event/mcallister-heart-institute-seminar-series-timothy-haystead-phd/
CATEGORIES:Medicine Grand Rounds
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20171019T120000
DTEND;TZID=America/New_York:20171019T130000
DTSTAMP:20260412T230639
CREATED:20171019T160000Z
LAST-MODIFIED:20190307T185822Z
UID:10000933-1508414400-1508418000@www.med.unc.edu
SUMMARY:Medicine Grand Rounds\, William Fischer and David Wohl\, "Ebola and Lassa Fever: New Concepts of Epidemiology and Therapy"
DESCRIPTION:Severe acute viral infections are one of the world’s most common causes of hospitalization and mortality with worse outcomes disproportionately affecting resource-constrained countries. In the past 15 years we have witnessed the emergence or re-emergence of several viral pathogens that threaten global public health including SARS\, pandemic H1N1 Influenza\, MERS-CoV\, and most recently Ebola.  \n\nFischer\, assistant professor in the Division of Pulmonary and Critical Care Medicine\, was among the first physicians on the ground in Guinea\, West Africa\, caring for patients during that country’s Ebola outbreak. He later teamed up with David Wohl\, MD\, professor of medicine in the Division of Infectious Diseases\, in Liberia. In collaboration with health care providers from Liberia and a clinical research organization called Clinical RM\, they launched the first clinical trial of a therapeutic intervention in an Ebola outbreak\, in which plasma from survivors of Ebola virus disease is given to patients who are battling the disease. \n“Our model has always been to couple direct service with clinical research\, with the idea being that if our freezers went down and we lost all of our research samples we were still providing an incredibly important service to patients” said Fischer.
URL:https://www.med.unc.edu/medicine/event/oct-19/
CATEGORIES:Medicine Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/medicine/wp-content/uploads/sites/945/2018/12/david-wohl-e1586534510632.jpeg
END:VEVENT
END:VCALENDAR